REGENXBIO Inc. (RGNX) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Pivotal Trial Enrollment for RGX202 in Affinity Duchenne | 30.00 | FY2025-Q4 |
| Zolgensma Royalalties Revenue | 18.4M | FY2025-Q2 |
Back to RGNX overview · RGNX earnings · RGNX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.